- Investing Ideas
- German Pharmaceuticals & Biotech Undervalued over 20% based on DCF
German Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
3
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
3 companies
SCHOTT Pharma KGaA
Market Cap: €2.1b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€13.68
7D
-0.1%
1Y
-31.2%
Gerresheimer
Market Cap: €587.2m
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€17.00
7D
-8.4%
1Y
-68.4%
Formycon
Market Cap: €315.5m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€17.86
7D
-4.1%
1Y
-18.3%